Literature DB >> 16772458

Serum iron curves can be used to estimate dietary iron bioavailability in humans.

Rana E Conway1, Catherine A Geissler, Robert C Hider, Richard P H Thompson, Jonathan J Powell.   

Abstract

Erythrocyte incorporation of isotopic iron (Fe) is the standard method for assessing iron bioavailability, but the process is expensive, technically difficult, and gives no information on the kinetics of absorption. The main objective of this study was to validate serum Fe curves as measures of dietary iron absorption because previous work demonstrated that serum iron curves can be generated with iron doses as low as 5-20 mg and that up to 20 mg iron can be added to meals without affecting relative absorption. In 3 studies, groups (n = 10, 10, 21) of Fe-deficient, mildly anemic women consumed meals of varying calculated Fe bioavailability, with and without added ferric chloride (10 mg Fe). Blood samples were collected at baseline and every 30 min for 4 h after the meal. Serum Fe concentrations were measured. Areas under the serum Fe curves and peak concentrations were used in different models to estimate Fe absorption and uptake. In 21 subjects, (58)Fe-enriched ferric chloride was added to the meals, and blood was taken 2 wk later to calculate red cell isotope incorporation. The addition of 10 mg Fe to test meals produced measurable serum iron curves even when the meal Fe bioavailability was low. Serum Fe curves were highly reproducible and were affected as expected by food composition. Even the single measurement at the estimated time of peak iron concentration was correlated significantly with erythrocyte incorporation of (58)Fe (r = 0.72, P < 0.0001). Hence the extent and rate of absorption of nonheme iron from meals, rather than in individuals, can be investigated with such subjects without the need for isotopes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772458     DOI: 10.1093/jn/136.7.1910

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  17 in total

1.  The iron-chelating potential of silybin in patients with hereditary haemochromatosis.

Authors:  C Hutchinson; A Bomford; C A Geissler
Journal:  Eur J Clin Nutr       Date:  2010-07-14       Impact factor: 4.016

2.  An algorithm to assess intestinal iron availability for use in dietary surveys.

Authors:  Anna P Rickard; Mark D Chatfield; Rana E Conway; Alison M Stephen; Jonathan J Powell
Journal:  Br J Nutr       Date:  2009-08-27       Impact factor: 3.718

3.  Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans.

Authors:  Carlos Contreras; María Dolores Barnuevo; Isabel Guillén; Antonio Luque; Elisabet Lázaro; Jordi Espadaler; Javier López-Román; José A Villegas
Journal:  Eur J Nutr       Date:  2013-07-27       Impact factor: 5.614

Review 4.  A review of iron studies in overweight and obese children and adolescents: a double burden in the young?

Authors:  Carol Hutchinson
Journal:  Eur J Nutr       Date:  2016-02-16       Impact factor: 5.614

5.  Salivary Cystatin SN Binds to Phytic Acid In Vitro and Is a Predictor of Nonheme Iron Bioavailability with Phytic Acid Supplementation in a Proof of Concept Pilot Study.

Authors:  Nicole M Delimont; Benjamin B Katz; Nicole M Fiorentino; Katheryne A Kimmel; Mark D Haub; Sara K Rosenkranz; John M Tomich; Brian L Lindshield
Journal:  Curr Dev Nutr       Date:  2019-04-20

6.  Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.

Authors:  Carol Hutchinson; Catherine A Geissler; Jonathan J Powell; Adrian Bomford
Journal:  Gut       Date:  2007-03-07       Impact factor: 23.059

7.  Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease.

Authors:  Miranda C E Lomer; William B Cook; Hamid Jan B Jan-Mohamed; Carol Hutchinson; Ding Yong Liu; Robert C Hider; Jonathan J Powell
Journal:  Br J Nutr       Date:  2011-12-09       Impact factor: 3.718

8.  Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease.

Authors:  Jonathan J Powell; William B Cook; Mark Chatfield; Carol Hutchinson; Dora Ia Pereira; Miranda Ce Lomer
Journal:  Nutr Metab (Lond)       Date:  2013-02-01       Impact factor: 4.169

9.  Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease.

Authors:  Jonathan J Powell; William B Cook; Carol Hutchinson; Zoe Tolkien; Mark Chatfield; Dora Ia Pereira; Miranda Ce Lomer
Journal:  Nutr Metab (Lond)       Date:  2013-01-15       Impact factor: 4.169

Review 10.  Potential of phytase-mediated iron release from cereal-based foods: a quantitative view.

Authors:  Anne V F Nielsen; Inge Tetens; Anne S Meyer
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.